According to the 2016 WHO update, gliomas are classified as contained gliomas (WHO grade I) or diffusely infiltrating gliomas (WHO grade II–IV) based on their development pattern and the presence or absence of an isocitrate dehydrogenase (IDH) mutation [2]. The gene discussed is IDH1; the disease is glioma.